Skip to main navigation Skip to search Skip to main content

Angiotensin Converting Enzyme Inhibition and Mortality in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)

  • PVRI-GoDeep-Consortium

Research output: Contribution to journalLetterpeer-review

Abstract

In 567 PH-COPD patients from the PVRI GoDeep Meta-Registry, ACE inhibitor use was associated with improved survival only in severe PH (PVR > 5 WU), supporting prospective trials targeting this high-risk subgroup.

Original languageEnglish (US)
Article numbere70348
JournalPulmonary Circulation
Volume16
Issue number3
DOIs
StatePublished - Jul 2026

Bibliographical note

Publisher Copyright:
© 2026 The Author(s). Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Angiotensin Converting Enzyme Inhibition and Mortality in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)'. Together they form a unique fingerprint.

Cite this